about
Dietary exposure to soy or whey proteins alters colonic global gene expression profiles during rat colon tumorigenesis.Medical treatment for gastro-entero-pancreatic neuroendocrine tumoursClinical utility of lanreotide AutogelĀ® in gastroenteropancreatic neuroendocrine tumorsSomatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives.Global analysis of the eukaryotic pathways and networks regulated by Salmonella typhimurium in mouse intestinal infection in vivo.Relationship between somatostatin receptor subtype expression and clinicopathology, Ki-67, Bcl-2 and p53 in colorectal cancer.Somatostatin receptor-1 induces cell cycle arrest and inhibits tumor growth in pancreatic cancer.Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosisSomatostatins and their role in thyroid cancer.Effects of octreotide and insulin on colon cancer cellular proliferation and correlation with hTERT activitySomatostatin analogs and radiopeptides in cancer therapy.Peptides with anticancer use or potential.Treatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review.Receptor-mediated tumor targeting with radiopeptides. Part 1. General concepts and methods: applications to somatostatin receptor-expressing tumors.Management of midgut carcinoids.Management of gastrointestinal carcinoid tumours - 10 years experience at a district general hospital.Differential somatostatin receptor (SSTR) 1-5 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumorsAlteration of somatostatin receptor subtype 2 gene expression in pancreatic tumor angiogenesisBiology and treatment of metastatic gastrointestinal neuroendocrine tumors.Somatostatin analogs therapy in gastroenteropancreatic neuroendocrine tumors: current aspects and new perspectives.A review of systemic and liver-directed therapies for metastatic neuroendocrine tumors of the gastroenteropancreatic tract.Improvement of drug-like properties of peptides: the somatostatin paradigm.The expanding role of somatostatin analogs in gastroenteropancreatic and lung neuroendocrine tumors.Somatostatin analogues in functioning gastroenteropancreatic neuroendocrine tumours: literature review, clinical recommendations and schedules.Pharmacotherapeutic Targeting of G Protein-Coupled Receptors in Oncology: Examples of Approved Therapies and Emerging Concepts.Expression of somatostatin receptors in human melanoma cell lines: effect of two different somatostatin analogues, octreotide and SOM230, on cell proliferation.Malignant irreversible intestinal obstruction: the powerful association of octreotide to corticosteroids, antiemetics, and analgesics.Antineoplastic effects of octreotide on human gallbladder cancer cells in vitro.Antiproliferative effect of octreotide on gastric cancer cells mediated by inhibition of Akt/PKB and telomerase.Non-invasive gamma camera imaging of gene transfer using an adenoviral vector encoding an epitope-tagged receptor as a reporter.Somatostatin receptor 1-5; expression profiles during rat development.Somatostatin analogs for gastric carcinoids: For many, but not all.Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors.Contemporary methods of therapy and follow-up of neuroendocrine tumours of the gastrointestinal tract and the pancreas.Successful receptor-mediated radiation therapy of xenografted human midgut carcinoid tumour.Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma.Randomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours.Anti-migratory and anti-invasive effect of somatostatin in human neuroblastoma cells: involvement of Rac and MAP kinase activity.Efficacy of docetaxel as a second-line chemotherapy for thymic carcinoma.Radiolabeling strategies for radionuclide imaging of stem cells.
P2860
Q24808665-14210428-6758-44DB-9E77-897AD6600744Q26751659-7CEAE594-1017-44B2-A1AF-076B5CC0B0F4Q28069632-021C7A2C-1230-4019-8BFA-7219A897762BQ33753449-D39DD174-2CD0-4BA6-9C04-4AA5BF88186AQ33776168-2FBD8D7A-7997-4E02-9F62-36563C5C89D3Q33867261-32C18079-3514-43C9-B5DF-5F181AE084ABQ34091373-D024882B-A236-4CAE-ABE5-E33B12683800Q34466979-FBF7C3A4-EABC-4171-9391-AE2DEFBF4D87Q34626992-16DC3144-3A39-4F2E-8338-5856032EE95FQ34832716-2F79E793-1A0F-446A-B61A-92383DD55E74Q34972896-07DA99F8-B52D-4264-BC5A-045E994C5C11Q35167010-2696C3BB-59BD-4097-9513-7ED95ADFDEFAQ35371197-F7F542DB-5DFB-4777-8117-529DC3415C4AQ36008285-955ECB2A-2455-4C75-917E-89598428EB02Q36047398-0130D051-8C0E-4767-8B64-C67093EAC832Q36097278-7932B157-8D91-44E6-B087-2C2FA0BECC51Q36270932-D9614B07-C0DC-4AF4-B226-517D51D5A2A8Q36474555-A1CE4E8C-4259-4EFE-B4AF-C904C3E2C61DQ37077832-D16B9C95-8840-402A-BC89-47603D992951Q37564373-E340909A-067B-477F-843C-51E5B665E595Q37859615-A257D5CE-4D5E-4B6D-8B5E-86C95D18C6D4Q38028559-59C49745-368A-4129-B1CB-7390A89FCB44Q38441413-BF5E6786-4D94-4B9C-8402-06E075FCE151Q38647297-1B6DC953-597C-4DB2-AFC6-866CDF67EB71Q39236911-2E18D8FC-34D1-42D0-8FFB-FF95A2E46AF1Q39741277-876BF08B-A7E1-4908-82D8-3915A5BC40B7Q40017863-9DBEAE1E-8AD2-4AF0-8AFF-3D8A51723AD8Q40571857-73C25177-F8AB-4982-B816-B76CE56B791DQ40625583-F51B182F-2020-4B1C-82D6-23A5FEFB778BQ40672503-C1BE0279-DA41-4676-A107-FDDD2726C58EQ40995512-1FEF948D-4169-44BE-A79A-8AFC7F565420Q42533692-45444606-0759-4986-A911-56DB689B8422Q42744657-6C009D19-B281-4B6A-B74D-2BD0BCB55975Q43121154-2F135A2C-EEBD-40E2-823C-8A934CF71058Q43200565-891A8B67-544D-43AF-ACAF-207425CB4472Q43921041-EFD3AF71-6302-428B-B65A-17F7A084ECD3Q44479307-637BA53E-74DB-41CC-A9D9-6C1621E9B034Q44539300-E6F57F2C-4D8C-49DA-846A-14062F54346DQ45193854-060D7156-E661-46BF-B58D-245E1C02887AQ48692331-5E6DD6D9-3243-4139-A357-0F546182B1E8
P2860
description
2001 nĆ® lÅ«n-bĆ»n
@nan
2001 Õ©ÕøÖÕ”ÕÆÕ”Õ¶Õ« Õ
ÕøÖÕ¶ÕøÖÕ”ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕøÖÕ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ ÕµÖ
Õ¤ÕøÖÕ”Õ®
@hyw
2001 Õ©Õ¾Õ”ÕÆÕ”Õ¶Õ« Õ°ÕøÖÕ¶Õ¾Õ”ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕ¾Õ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ Õ°ÕøÕ¤Õ¾Õ”Õ®
@hy
2001幓ć®č«ę
@ja
2001幓č«ę
@yue
2001幓č«ę
@zh-hant
2001幓č«ę
@zh-hk
2001幓č«ę
@zh-mo
2001幓č«ę
@zh-tw
2001幓č®ŗę
@wuu
name
Antiproliferative effect of somatostatin and analogs.
@ast
Antiproliferative effect of somatostatin and analogs.
@en
Antiproliferative effect of somatostatin and analogs.
@nl
type
label
Antiproliferative effect of somatostatin and analogs.
@ast
Antiproliferative effect of somatostatin and analogs.
@en
Antiproliferative effect of somatostatin and analogs.
@nl
prefLabel
Antiproliferative effect of somatostatin and analogs.
@ast
Antiproliferative effect of somatostatin and analogs.
@en
Antiproliferative effect of somatostatin and analogs.
@nl
P2093
P356
P1433
P1476
Antiproliferative effect of somatostatin and analogs.
@en
P2093
P356
10.1159/000049159
P478
47 Suppl 2
P577
2001-01-01T00:00:00Z